a developer of non-invasive blood tests for the early detection of solid tumor based cancers
Industry Biotechnology
A.I.dvisor tells us that ANIX and ATYR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANIX and ATYR's prices will move in lockstep.
Ticker / NAME | Correlation To ANIX | 1D Price Change % | ||
---|---|---|---|---|
ANIX | 100% | +3.43% | ||
ATYR - ANIX | 29% Poorly correlated | +16.06% | ||
CDTX - ANIX | 27% Poorly correlated | +2.62% | ||
GERN - ANIX | 27% Poorly correlated | +0.12% | ||
CLRB - ANIX | 25% Poorly correlated | +1.28% | ||
SER - ANIX | 24% Poorly correlated | +9.29% | ||
More |